{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:58:18Z","timestamp":1785700698652,"version":"3.56.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,12]],"date-time":"2027-06-12T00:00:00Z","timestamp":1812758400000},"content-version":"am","delay-in-days":315,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA108904"],"award-info":[{"award-number":["CA108904"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bbrc.2026.154134","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:22:44Z","timestamp":1781104964000},"page":"154134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Constitutively active MEK1 expression driven by the myeloid-selective MRP8 promoter induces epithelial hyperplasia and papilloma formation"],"prefix":"10.1016","volume":"828","author":[{"given":"Yan","family":"Zang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranhui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle B.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3921-0593","authenticated-orcid":false,"given":"Lora H.","family":"Rigatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154134_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1541-7786.MCR-20-0687","article-title":"The MEK\/ERK network as a therapeutic target in human cancer","volume":"19","author":"Barbosa","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154134_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.gendis.2022.05.006","article-title":"Targeting RAS-RAF-MEK-ERK signaling pathway in human cancer: current status in clinical trials","volume":"10","author":"Song","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.bbrc.2026.154134_bib3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/MCB.19.1.321","article-title":"Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis","volume":"19","author":"Treinies","year":"1999","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2026.154134_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119499","article-title":"Interplay between MAPK\/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression","volume":"278","author":"Asl","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbrc.2026.154134_bib5","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.onc.1202367","article-title":"Constitutive activation of the 41-\/43-kDa mitogen-activated protein kinase signaling pathway in human tumors","volume":"18","author":"Hoshino","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154134_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.leu.2400617","article-title":"Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells","volume":"11","author":"Towatari","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2026.154134_bib7","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","article-title":"Map kinase signaling pathways and hematologic malignancies","volume":"101","author":"Platanias","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.154134_bib8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.onc.1207192","article-title":"Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia","volume":"23","author":"Staber","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154134_bib9","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1073\/pnas.77.10.6152","article-title":"Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: a model for the origin and progression of malignancy","volume":"77","author":"Sachs","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154134_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev.immunol.21.120601.141007","article-title":"Biology of hematopoietic stem cells and progenitors: implications for clinical application","volume":"21","author":"Kondo","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2026.154134_bib11","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.leu.2402400","article-title":"Importance of MEK-1\/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines","volume":"16","author":"Miranda","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2026.154134_bib12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.leukres.2005.03.016","article-title":"Cytokine-induced myeloid differentiation is dependent on activation of the MEK\/ERK pathway","volume":"29","author":"Miranda","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2026.154134_bib13","first-page":"191","article-title":"Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line","volume":"11","author":"Hu","year":"2000","journal-title":"Cell Growth Differ."},{"key":"10.1016\/j.bbrc.2026.154134_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028350","article-title":"Constitutive MAP kinase activation in hematopoietic stem cells induces a myeloproliferative disorder","volume":"6","author":"Chung","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154134_bib15","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.V79.8.1907.1907","article-title":"Mouse MRP8 and MRP14, two intracellular calcium-binding proteins associated with the development of the myeloid lineage","volume":"79","author":"Lagasse","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2026.154134_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1084\/jem.179.3.1047","article-title":"bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages","volume":"179","author":"Lagasse","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2026.154134_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jlb.53.2.197","article-title":"MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes","volume":"53","author":"Hessian","year":"1993","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbrc.2026.154134_bib18","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.94.6.2551","article-title":"A PMLRARalpha transgene initiates murine acute promyelocytic leukemia","volume":"94","author":"Brown","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154134_bib19","doi-asserted-by":"crossref","first-page":"11863","DOI":"10.1073\/pnas.95.20.11863","article-title":"The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia","volume":"95","author":"Kogan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154134_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.4161\/cbt.29452","article-title":"Carfilzomib and oprozomib synergize with histone deacetylase inhibitors in head and neck squamous cell carcinoma models of acquired resistance to proteasome inhibitors","volume":"15","author":"Zang","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2026.154134_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.0022-202X.2004.23225.x","article-title":"Expression of activated MEK1 in differentiating epidermal cells is sufficient to generate hyperproliferative and inflammatory skin lesions","volume":"123","author":"Hobbs","year":"2004","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2026.154134_bib22","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1158\/0008-5472.CAN-04-0017","article-title":"Mek1 alters epidermal growth and differentiation","volume":"64","author":"Scholl","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154134_bib23","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/sj.bjc.6606009","article-title":"Ras and Raf pathways in epidermis development and carcinogenesis","volume":"104","author":"Kern","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrc.2026.154134_bib24","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1158\/0008-5472.CAN-05-3129","article-title":"p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1)-dependent signaling contributes to epithelial skin carcinogenesis","volume":"66","author":"Bourcier","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154134_bib25","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1158\/0008-5472.CAN-08-1963","article-title":"Selective role for Mek1 but not Mek2 in the induction of epidermal neoplasia","volume":"69","author":"Scholl","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2026.154134_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1365-2133.2003.05536.x","article-title":"Proinflammatory cytokines upregulate expression of calprotectin (L1 protein, MRP-8\/MRP-14) in cultured human keratinocytes","volume":"149","author":"Mork","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbrc.2026.154134_bib27","article-title":"Interleukin 17 promotes expression of alarmins S100A8 and S100A9 during the inflammatory response of keratinocytes","volume":"11","author":"Christmann","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154134_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF00372067","article-title":"Epidermal expression of the calcium binding surface antigen 27E10 in inflammatory skin diseases","volume":"284","author":"Kunz","year":"1992","journal-title":"Arch. Dermatol. Res."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008983?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26008983?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:44:15Z","timestamp":1785699855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26008983"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S0006291X26008983"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154134","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constitutively active MEK1 expression driven by the myeloid-selective MRP8 promoter induces epithelial hyperplasia and papilloma formation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154134"}}